phloroglucinol has been researched along with aristoforin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gartner, M; Giannis, A; Müller, T; Simon, JC; Sleeman, JP | 1 |
Büttner, A; Gey, C; Giannis, A; Hennig, L; Kyrylenko, S; Nguyen, LH; Pham, HD | 1 |
Bruyère, F; Gartner, M; Giannis, A; Noël, A; Plaumann, D; Rothley, M; Schacht, V; Schmid, A; Sleeman, JP; Thiele, W; Yektaoglu, A | 1 |
Fedoročko, P; Jendželovský, R; Mikeš, J; Šemeláková, M | 1 |
Fedoročko, P; Gálová, E; Imreová, P; Kožurková, M; Loderer, D; Miadoková, E; Plšíková, J; Šemeláková, M; Ševčovičová, A | 1 |
Fedoročko, P; Jendželovský, R; Šemeláková, M | 1 |
6 other study(ies) available for phloroglucinol and aristoforin
Article | Year |
---|---|
Aristoforin, a novel stable derivative of hyperforin, is a potent anticancer agent.
Topics: Animals; Antineoplastic Agents; Bridged Bicyclo Compounds; Drug Stability; Phloroglucinol; Rats; Solubility; Terpenes | 2005 |
Phloroglucinol derivatives guttiferone G, aristoforin, and hyperforin: inhibitors of human sirtuins SIRT1 and SIRT2.
Topics: Bridged Bicyclo Compounds; Cell Proliferation; Cells, Cultured; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Phloroglucinol; Sirtuin 1; Sirtuin 2; Sirtuins; Terpenes | 2007 |
Hyperforin and aristoforin inhibit lymphatic endothelial cell proliferation in vitro and suppress tumor-induced lymphangiogenesis in vivo.
Topics: Animals; Aorta, Thoracic; Apoptosis; Bridged Bicyclo Compounds; Caspase 3; Caspase 8; Cell Cycle; Cell Proliferation; Cells, Cultured; Cytochromes c; Endothelial Cells; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Lymphangiogenesis; Membrane Potential, Mitochondrial; Mitochondria; Neoplasms, Experimental; Phloroglucinol; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Terpenes; Xenograft Model Antitumor Assays | 2009 |
The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells.
Topics: Adenocarcinoma; Anthracenes; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Enzyme Activation; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Intracellular Space; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Membrane Potential, Mitochondrial; Neoplasm Invasiveness; Perylene; Phloroglucinol; Photochemotherapy; Reactive Oxygen Species; Terpenes | 2012 |
DNA-protective activities of hyperforin and aristoforin.
Topics: Antioxidants; DNA; DNA Breaks; Free Radical Scavengers; Hypericum; Iron; Iron Chelating Agents; Phloroglucinol; Terpenes; Topoisomerase I Inhibitors | 2015 |
Drug membrane transporters and CYP3A4 are affected by hypericin, hyperforin or aristoforin in colon adenocarcinoma cells.
Topics: Adenocarcinoma; Anthracenes; Blotting, Western; Cell Line, Tumor; Colonic Neoplasms; Cytochrome P-450 CYP3A; Firefly Luciferin; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Intracellular Space; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Neoplasm Proteins; Perylene; Phloroglucinol; Real-Time Polymerase Chain Reaction; Terpenes | 2016 |